Peter Seubert

27.5k total citations · 5 hit papers
81 papers, 13.3k citations indexed

About

Peter Seubert is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter Seubert has authored 81 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Physiology, 36 papers in Molecular Biology and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter Seubert's work include Alzheimer's disease research and treatments (56 papers), Computational Drug Discovery Methods (16 papers) and Neuroscience and Neuropharmacology Research (16 papers). Peter Seubert is often cited by papers focused on Alzheimer's disease research and treatments (56 papers), Computational Drug Discovery Methods (16 papers) and Neuroscience and Neuropharmacology Research (16 papers). Peter Seubert collaborates with scholars based in United States, Canada and Germany. Peter Seubert's co-authors include Dale Schenk, Dennis J. Selkoe, Ivan Lieberburg, Dora Games, Robin Barbour, Martin Citron, Carmen Vigo‐Pelfrey, Christian Haass, Gary Lynch and Lisa McConlogue and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter Seubert

81 papers receiving 13.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

1992 1.5k citations Peter Seubert, Michael Lee et al. profile →
Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

1992 1.4k citations Tilman Oltersdorf, Peter Seubert et al. profile →
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

2006 1.1k citations Jason Goldstein, Robin Barbour et al. Journal of Biological Chemistry profile →
Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease

1995 568 citations Ruth Motter, Dora Kholodenko et al. Annals of Neurology profile →
Amyloid precursor protein processing and Aβ ₄₂ deposition in a transgenic mouse model of Alzheimer disease

1997 553 citations Kelly Johnson‐Wood, Ruth Motter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Seubert United States	50	9.7k	5.4k	3.1k	2.5k	2.4k	81	13.3k
Dale Schenk United States	49	11.1k 1.1×	5.4k 1.0×	2.9k 0.9×	2.3k 0.9×	2.7k 1.1×	84	14.3k
Martin Citron United States	48	10.5k 1.1×	5.7k 1.1×	2.8k 0.9×	1.8k 0.7×	1.5k 0.6×	86	13.8k
Mikio Shoji Japan	55	7.0k 0.7×	5.5k 1.0×	2.7k 0.9×	1.9k 0.8×	1.8k 0.8×	293	12.0k
Kelly R. Bales United States	66	12.1k 1.2×	6.1k 1.1×	3.9k 1.2×	1.4k 0.6×	3.8k 1.6×	126	17.1k
Jorge Ghiso United States	70	11.8k 1.2×	8.5k 1.6×	1.9k 0.6×	2.1k 0.8×	2.8k 1.2×	213	17.3k
Massimo Tabaton Italy	57	8.0k 0.8×	5.0k 0.9×	2.3k 0.7×	3.1k 1.3×	2.4k 1.0×	163	12.9k
Karen H. Ashe United States	45	11.9k 1.2×	5.5k 1.0×	4.9k 1.6×	1.2k 0.5×	3.9k 1.6×	88	15.7k
Linda H. Younkin United States	44	9.2k 1.0×	4.6k 0.8×	2.8k 0.9×	785 0.3×	2.5k 1.1×	72	12.1k
Christopher B. Eckman United States	50	9.3k 1.0×	5.9k 1.1×	2.3k 0.8×	791 0.3×	1.5k 0.6×	78	12.6k
Marc Mercken Belgium	44	7.9k 0.8×	4.3k 0.8×	2.3k 0.7×	877 0.4×	1.6k 0.7×	102	10.8k

Countries citing papers authored by Peter Seubert

Since Specialization

Citations

This map shows the geographic impact of Peter Seubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Seubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Seubert more than expected).

Fields of papers citing papers by Peter Seubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Seubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Seubert. The network helps show where Peter Seubert may publish in the future.

Co-authorship network of co-authors of Peter Seubert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Seubert. A scholar is included among the top collaborators of Peter Seubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Seubert. Peter Seubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zago, Wagner, Manuel Buttini, Thomas A. Comery, et al.. (2012). Neutralization of Soluble, Synaptotoxic Amyloid β Species by Antibodies Is Epitope Specific. Journal of Neuroscience. 32(8). 2696–2702. 53 indexed citations

Bekris, Lynn M., Steven P. Millard, David J. Lockhart, et al.. (2011). Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiology of Aging. 32(3). 556.e13–556.e23. 45 indexed citations

Seubert, Peter, Robin Barbour, Karen Khan, et al.. (2008). Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse. Neurodegenerative Diseases. 5(2). 65–71. 55 indexed citations

Slemmon, J. Randall, et al.. (2006). Distribution of Aβ peptide in whole blood. Journal of Chromatography B. 846(1-2). 24–31. 11 indexed citations

Lee, Michael, Frédérique Bard, Kelly Johnson‐Wood, et al.. (2005). Aβ42 immunization in Alzheimer's disease generates Aβ N-terminal antibodies. Annals of Neurology. 58(3). 430–435. 107 indexed citations

Masliah, Eliezer, Edward Rockenstein, Anthony Adame, et al.. (2005). Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease. Neuron. 46(6). 857–868. 423 indexed citations

Schenk, Dale, Peter Seubert, & Richard B. Ciccarelli. (2001). Immunotherapy with β -Amyloid for Alzheimer's Disease: A New Frontier. DNA and Cell Biology. 20(11). 679–681. 21 indexed citations

Brayden, David J., Siobhán McClean, Robin Barbour, et al.. (2001). Encapsulation in biodegradable microparticles enhances serum antibody response to parenterally-delivered β-amyloid in mice. Vaccine. 19(30). 4185–4193. 18 indexed citations

Schenk, Dale B., Peter Seubert, Ivan Lieberburg, & John L. Wallace. (2000). β-Peptide Immunization. Archives of Neurology. 57(7). 934–934. 61 indexed citations

10.

Xia, Weiming, Jimin Zhang, Beth L. Ostaszewski, et al.. (1998). Presenilin 1 Regulates the Processing of β-Amyloid Precursor Protein C-Terminal Fragments and the Generation of Amyloid β-Protein in Endoplasmic Reticulum and Golgi. Biochemistry. 37(47). 16465–16471. 148 indexed citations

11.

Gómez‐Isla, Teresa, Wilma Wasco, Sarada Gurubhagavatula, et al.. (1997). A novel presenilin‐1 mutation: Increased β‐amyloid and neurofibrillary changes. Annals of Neurology. 41(6). 809–813. 60 indexed citations

12.

Galasko, Doug, Christopher M. Clark, Lei Chang, et al.. (1997). Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology. 48(3). 632–635. 110 indexed citations

13.

Johnson, G V, et al.. (1997). The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments. Journal of Neurochemistry. 68(1). 430–433. 133 indexed citations

14.

Seubert, Peter, Madhumalti Mawal-Dewan, Robin Barbour, et al.. (1995). Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau. Journal of Biological Chemistry. 270(32). 18917–18922. 306 indexed citations

15.

Johnson‐Wood, Kelly, Thomas Henriksson, Peter Seubert, et al.. (1994). Identification of Secreted β-Amyloid Precursor Protein Binding Sites on Intact Human Fibroblasts. Biochemical and Biophysical Research Communications. 200(3). 1685–1692. 4 indexed citations

16.

Lynch, Gary & Peter Seubert. (1989). Links between Long‐Term Potentiation and Neuropathology An Hypothesis Involving Calcium‐Activated Proteases. Annals of the New York Academy of Sciences. 568(1). 171–180. 22 indexed citations

17.

Seubert, Peter, Gwen O. Ivy, John Larson, et al.. (1988). Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. I. Biochemical studies. Brain Research. 459(2). 226–232. 75 indexed citations

18.

Ivy, Gwen O., Peter Seubert, Gary Lynch, & Michel Baudry. (1988). Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. II. Anatomical studies. Brain Research. 459(2). 233–240. 15 indexed citations

19.

Lynch, Gary, Dominique Müller, Peter Seubert, & John Larson. (1988). Long-term potentiation: Persisting problems and recent results. Brain Research Bulletin. 21(3). 363–372. 66 indexed citations

20.

Farley, Jonathan, et al.. (1979). Adenosine triphosphate sulfurylase from Penicillium chrysogenum. Evidence for essential arginine, histidine, and tyrosine residues.. Journal of Biological Chemistry. 254(9). 3537–3542. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact